Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

medRxiv logoLink to medRxiv
[Preprint]. 2024 Oct 17:2024.10.16.24315096. [Version 1] doi: 10.1101/2024.10.16.24315096

Isolated prolapse of the posterior mitral valve leaflet: phenotypic refinement, heritability and genetic etiology

Antoine Rimbert, Damien Duval, Daniel Trujillano, Florence Kyndt, Antoine Jobbe-Duval, Pierre Lindenbaum, Nathan Tucker, Simon Lecointe, Pauline Labbé, Claire Toquet, Matilde Karakachoff, Jean-Christian Roussel, Christophe Baufreton, Patrick Bruneval, Caroline Cueff, Erwan Donal, Richard Redon, Robert Olaso, Anne Boland, Jean-François Deleuze; FranceGenRef Consortium, Xavier Estivill, Susan Slaugenhaupt, Roger R Markwald, Russel A Norris, Jean-Philippe Verhoye, Vincent Probst, Albert Hagège, Robert Levine, Xavier Jeunemaitre, Hervé Le Marec, Romain Capoulade, Nabila Bouatia-Naji, Christian Dina, David Milan, Stephan Ossowski, Jean-Jacques Schott, Jean Mérot, Solena Le Scouarnec, Thierry Le Tourneau
PMCID: PMC11527059  PMID: 39484266

ABSTRACT

BACKGROUND

Isolated posterior leaflet mitral valve prolapse (PostMVP), a common form of MVP, often referred as fibroelastic deficiency, is considered a degenerative disease. PostMVP patients are usually asymptomatic and often undiagnosed until chordal rupture. The present study aims to characterize familial PostMVP phenotype and familial recurrence, its genetic background, and the pathophysiological processes involved.

METHODS

We prospectively enrolled 284 unrelated MVP probands, of whom 178 (63%) had bi-leaflet MVP and 106 had PostMVP (37%). Familial screening within PostMVP patients allowed the identification of 20 families with inherited forms of PostMVP for whom whole genome sequencing was carried out in probands. Functional in vivo and in vitro investigations were performed in zebrafishand in Hek293T cells.

RESULTS

In the 20 families with inherited form of PostMVP, 38.8% of relatives had a MVP/prodromal form, mainly of the posterior leaflet, with transmission consistent with an autosomal dominant mode of inheritance. Compared with control relatives, PostMVP family patients have clear posterior leaflet dystrophy on echocardiography. Patients with PostMVP present a burden of rare genetic variants in ARHGAP24. ARHGAP24 encodes the filamin A binding RhoGTPase-activating protein FilGAP and its silencing in zebrafish leads to atrioventricular regurgitation. In vitro functional studies showed that variants of FilGAP, found in PostMVP families, are loss-of-function variants impairing cellular adhesion and mechano-transduction capacities.

CONCLUSIONS

PostMVP should not only be considered an isolated degenerative pathology but as a specific heritable phenotypic trait with genetic and functional pathophysiological origins. The identification of loss-of-function variants in ARHGAP24 further reinforces the pivotal role of mechano-transduction pathways in the pathogenesis of MVP.

CLINICAL PERSPECTIVE

  • Isolated posterior mitral valve prolapse (PostMVP), often called fibro-elastic deficiency MVP, is at least in some patients, a specific inherited phenotypic trait

  • PostMVP has both genetic and functional pathophysiological origins

  • Genetic variants in the ARHGAP24 gene, which encodes for the FilGAP protein, cause progressive Post MVP in familial cases, and impair cell adhesion and mechano-transduction capacities

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.


Articles from medRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES